| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometriosis | 32 | 2026 | 83 | 9.470 |
Why?
|
| Endometrium | 9 | 2020 | 59 | 3.200 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 1070 | 1.300 |
Why?
|
| Infertility, Female | 3 | 2015 | 24 | 0.880 |
Why?
|
| Chemokine CXCL12 | 2 | 2018 | 32 | 0.870 |
Why?
|
| Pelvic Pain | 3 | 2024 | 10 | 0.860 |
Why?
|
| Receptors, CXCR4 | 2 | 2018 | 74 | 0.840 |
Why?
|
| Female | 46 | 2026 | 24698 | 0.830 |
Why?
|
| Endometrial Neoplasms | 1 | 2025 | 79 | 0.820 |
Why?
|
| Stress, Psychological | 9 | 2024 | 661 | 0.810 |
Why?
|
| Quality of Life | 4 | 2020 | 616 | 0.810 |
Why?
|
| Immunohistochemistry | 6 | 2025 | 934 | 0.800 |
Why?
|
| Histones | 2 | 2015 | 197 | 0.770 |
Why?
|
| Puerto Rico | 13 | 2025 | 1413 | 0.730 |
Why?
|
| Enzyme Inhibitors | 2 | 2020 | 458 | 0.680 |
Why?
|
| Adult | 23 | 2026 | 13872 | 0.640 |
Why?
|
| Tissue Array Analysis | 5 | 2025 | 80 | 0.630 |
Why?
|
| Activities of Daily Living | 2 | 2011 | 139 | 0.620 |
Why?
|
| Private Sector | 1 | 2019 | 10 | 0.610 |
Why?
|
| Ki-67 Antigen | 1 | 2019 | 34 | 0.610 |
Why?
|
| Estrogen Receptor beta | 1 | 2019 | 39 | 0.610 |
Why?
|
| Receptors, Progesterone | 1 | 2019 | 92 | 0.590 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 121 | 0.570 |
Why?
|
| Depression | 3 | 2024 | 863 | 0.560 |
Why?
|
| Insurance, Health | 1 | 2019 | 145 | 0.560 |
Why?
|
| Protein-Lysine 6-Oxidase | 2 | 2015 | 69 | 0.530 |
Why?
|
| Humans | 36 | 2026 | 43102 | 0.530 |
Why?
|
| Medicaid | 1 | 2019 | 143 | 0.530 |
Why?
|
| Adaptation, Psychological | 2 | 2018 | 420 | 0.520 |
Why?
|
| Middle Aged | 17 | 2025 | 12222 | 0.500 |
Why?
|
| Lysine | 2 | 2015 | 119 | 0.490 |
Why?
|
| Obesity | 1 | 2025 | 1151 | 0.490 |
Why?
|
| Anxiety | 4 | 2024 | 874 | 0.490 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 704 | 0.490 |
Why?
|
| Epigenesis, Genetic | 3 | 2026 | 291 | 0.490 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2020 | 1766 | 0.480 |
Why?
|
| Healthcare Disparities | 2 | 2019 | 590 | 0.480 |
Why?
|
| Disease Models, Animal | 12 | 2020 | 1596 | 0.440 |
Why?
|
| Uterine Contraction | 1 | 2014 | 3 | 0.440 |
Why?
|
| Progesterone | 2 | 2015 | 121 | 0.420 |
Why?
|
| Carcinoma, Endometrioid | 2 | 2025 | 20 | 0.420 |
Why?
|
| Cell Line | 5 | 2018 | 1410 | 0.410 |
Why?
|
| Biological Specimen Banks | 1 | 2014 | 28 | 0.410 |
Why?
|
| Congresses as Topic | 1 | 2014 | 50 | 0.410 |
Why?
|
| Young Adult | 9 | 2025 | 5080 | 0.390 |
Why?
|
| Estradiol | 2 | 2015 | 268 | 0.380 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2019 | 310 | 0.380 |
Why?
|
| Gastrointestinal Motility | 2 | 2014 | 20 | 0.380 |
Why?
|
| Histone Deacetylase 2 | 1 | 2012 | 5 | 0.370 |
Why?
|
| Histone Deacetylase 1 | 1 | 2012 | 16 | 0.370 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2026 | 863 | 0.360 |
Why?
|
| Epithelial Cells | 1 | 2015 | 434 | 0.350 |
Why?
|
| Complement C3 | 1 | 2011 | 16 | 0.350 |
Why?
|
| Efficiency | 1 | 2011 | 14 | 0.350 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2011 | 37 | 0.350 |
Why?
|
| Case-Control Studies | 6 | 2024 | 1285 | 0.340 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 3156 | 0.330 |
Why?
|
| Health Status Indicators | 1 | 2011 | 90 | 0.330 |
Why?
|
| Work | 1 | 2010 | 7 | 0.330 |
Why?
|
| Uterine Diseases | 1 | 2010 | 5 | 0.320 |
Why?
|
| Cell Proliferation | 4 | 2018 | 1455 | 0.320 |
Why?
|
| Rats | 12 | 2020 | 3735 | 0.320 |
Why?
|
| Biomedical Research | 2 | 2025 | 502 | 0.320 |
Why?
|
| Health | 1 | 2010 | 30 | 0.320 |
Why?
|
| Gene Expression | 3 | 2012 | 701 | 0.310 |
Why?
|
| Neoplasms | 3 | 2020 | 1377 | 0.310 |
Why?
|
| Indazoles | 2 | 2020 | 12 | 0.310 |
Why?
|
| Health Surveys | 1 | 2011 | 405 | 0.300 |
Why?
|
| Colorectal Neoplasms | 2 | 2025 | 512 | 0.300 |
Why?
|
| Cell Movement | 3 | 2018 | 655 | 0.300 |
Why?
|
| Pyridones | 2 | 2020 | 50 | 0.290 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 706 | 0.280 |
Why?
|
| Endometritis | 1 | 2007 | 2 | 0.280 |
Why?
|
| Breast Neoplasms | 3 | 2025 | 1723 | 0.270 |
Why?
|
| Lactobacillus | 1 | 2007 | 22 | 0.270 |
Why?
|
| Reproductive History | 1 | 2007 | 27 | 0.270 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 36 | 0.270 |
Why?
|
| Self Concept | 2 | 2024 | 171 | 0.260 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 455 | 0.260 |
Why?
|
| Animals | 18 | 2023 | 16992 | 0.260 |
Why?
|
| Aged | 9 | 2025 | 8214 | 0.260 |
Why?
|
| Cyclonic Storms | 2 | 2024 | 80 | 0.250 |
Why?
|
| Intestinal Diseases | 1 | 2005 | 6 | 0.240 |
Why?
|
| Risk Factors | 4 | 2026 | 3994 | 0.230 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2005 | 22 | 0.230 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2005 | 12 | 0.230 |
Why?
|
| Lymphocytes | 1 | 2006 | 124 | 0.230 |
Why?
|
| Polymorphism, Genetic | 2 | 2020 | 201 | 0.230 |
Why?
|
| Retrospective Studies | 2 | 2025 | 2544 | 0.230 |
Why?
|
| Spain | 1 | 2024 | 44 | 0.210 |
Why?
|
| Latin America | 1 | 2024 | 55 | 0.210 |
Why?
|
| Genome-Wide Association Study | 1 | 2026 | 423 | 0.210 |
Why?
|
| Health Status Disparities | 2 | 2024 | 719 | 0.200 |
Why?
|
| Behavior, Animal | 2 | 2017 | 373 | 0.200 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2023 | 21 | 0.200 |
Why?
|
| Adolescent | 4 | 2018 | 6081 | 0.200 |
Why?
|
| Uterus | 3 | 2020 | 52 | 0.200 |
Why?
|
| Mites | 1 | 2003 | 9 | 0.200 |
Why?
|
| Trypsin | 1 | 2003 | 40 | 0.200 |
Why?
|
| Pain Measurement | 1 | 2024 | 183 | 0.200 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 2853 | 0.190 |
Why?
|
| Adenocarcinoma | 1 | 2025 | 291 | 0.190 |
Why?
|
| DNA, Complementary | 1 | 2003 | 196 | 0.190 |
Why?
|
| Allergens | 1 | 2003 | 65 | 0.190 |
Why?
|
| Dust | 1 | 2003 | 57 | 0.190 |
Why?
|
| Cytokines | 1 | 2006 | 678 | 0.180 |
Why?
|
| Psychometrics | 1 | 2024 | 358 | 0.180 |
Why?
|
| Colitis | 3 | 2007 | 71 | 0.180 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 2 | 2018 | 26 | 0.180 |
Why?
|
| Mutation | 2 | 2025 | 1177 | 0.180 |
Why?
|
| Inflammation | 2 | 2020 | 758 | 0.170 |
Why?
|
| Alleles | 2 | 2020 | 352 | 0.170 |
Why?
|
| Blotting, Western | 2 | 2015 | 883 | 0.170 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2020 | 4 | 0.160 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 41 | 0.160 |
Why?
|
| Skin Pigmentation | 1 | 2020 | 23 | 0.160 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 55 | 0.160 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 1234 | 0.150 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 69 | 0.150 |
Why?
|
| Hysterectomy | 1 | 2019 | 38 | 0.150 |
Why?
|
| Laparoscopy | 1 | 2019 | 59 | 0.150 |
Why?
|
| Inflammation Mediators | 4 | 2020 | 140 | 0.150 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 415 | 0.140 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2018 | 1 | 0.140 |
Why?
|
| Pyrroles | 1 | 2018 | 72 | 0.140 |
Why?
|
| Vitamin D | 1 | 2020 | 196 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 178 | 0.140 |
Why?
|
| Benzylamines | 1 | 2018 | 7 | 0.140 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 36 | 0.140 |
Why?
|
| Housing, Animal | 1 | 2017 | 12 | 0.140 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2017 | 9 | 0.140 |
Why?
|
| Receptor, trkA | 1 | 2017 | 6 | 0.140 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 23 | 0.140 |
Why?
|
| Hypertension | 1 | 2025 | 835 | 0.140 |
Why?
|
| Nerve Growth Factor | 1 | 2017 | 29 | 0.140 |
Why?
|
| Colon | 3 | 2014 | 120 | 0.130 |
Why?
|
| Pyrimidines | 1 | 2018 | 139 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2019 | 383 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2024 | 568 | 0.130 |
Why?
|
| Neurogenesis | 1 | 2017 | 63 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2026 | 734 | 0.130 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 152 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 252 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 278 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2025 | 760 | 0.130 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2016 | 31 | 0.130 |
Why?
|
| Environment | 1 | 2017 | 149 | 0.120 |
Why?
|
| Periaqueductal Gray | 1 | 2016 | 11 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2017 | 172 | 0.120 |
Why?
|
| Macrophages | 1 | 2020 | 529 | 0.120 |
Why?
|
| Receptors, Opioid, mu | 1 | 2016 | 52 | 0.120 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 1063 | 0.120 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 135 | 0.110 |
Why?
|
| Stromal Cells | 2 | 2012 | 55 | 0.110 |
Why?
|
| Response Elements | 1 | 2015 | 55 | 0.110 |
Why?
|
| Methylation | 1 | 2015 | 119 | 0.110 |
Why?
|
| Defecation | 1 | 2014 | 6 | 0.110 |
Why?
|
| Biopsy | 1 | 2015 | 177 | 0.110 |
Why?
|
| Neutrophil Infiltration | 1 | 2014 | 28 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 166 | 0.110 |
Why?
|
| Gene Frequency | 2 | 2012 | 206 | 0.110 |
Why?
|
| Corticosterone | 1 | 2014 | 90 | 0.100 |
Why?
|
| Maze Learning | 1 | 2014 | 113 | 0.100 |
Why?
|
| Regional Health Planning | 1 | 2013 | 14 | 0.100 |
Why?
|
| Transfection | 1 | 2015 | 532 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 185 | 0.100 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 27 | 0.100 |
Why?
|
| Acetylation | 1 | 2013 | 107 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 384 | 0.100 |
Why?
|
| Minority Health | 1 | 2013 | 95 | 0.100 |
Why?
|
| Anti-HIV Agents | 1 | 2018 | 486 | 0.100 |
Why?
|
| Florida | 2 | 2025 | 478 | 0.100 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 4 | 0.090 |
Why?
|
| Skin Diseases | 1 | 2012 | 30 | 0.090 |
Why?
|
| Hormones | 1 | 2012 | 55 | 0.090 |
Why?
|
| ras Proteins | 1 | 2012 | 54 | 0.090 |
Why?
|
| Abortion, Spontaneous | 1 | 2012 | 27 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2012 | 51 | 0.090 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 86 | 0.090 |
Why?
|
| Disease Progression | 3 | 2018 | 667 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 236 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 138 | 0.080 |
Why?
|
| Health Records, Personal | 1 | 2010 | 6 | 0.080 |
Why?
|
| Leukocyte Count | 2 | 2012 | 69 | 0.080 |
Why?
|
| Male | 7 | 2025 | 23409 | 0.080 |
Why?
|
| Task Performance and Analysis | 1 | 2010 | 47 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 257 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2011 | 587 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2025 | 56 | 0.080 |
Why?
|
| Time Factors | 1 | 2014 | 1857 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2010 | 98 | 0.080 |
Why?
|
| Women's Health | 1 | 2010 | 160 | 0.070 |
Why?
|
| E-Selectin | 2 | 2005 | 23 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2005 | 59 | 0.070 |
Why?
|
| Mitochondrial Diseases | 1 | 2008 | 20 | 0.070 |
Why?
|
| Phenotype | 1 | 2011 | 780 | 0.070 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 48 | 0.070 |
Why?
|
| United States | 1 | 2019 | 5205 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2011 | 863 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 67 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2005 | 183 | 0.070 |
Why?
|
| Peroxidase | 1 | 2007 | 57 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2007 | 67 | 0.070 |
Why?
|
| DNA | 1 | 2010 | 592 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 191 | 0.060 |
Why?
|
| Binding Sites | 2 | 2012 | 671 | 0.060 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2005 | 3 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 1600 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2012 | 518 | 0.060 |
Why?
|
| Peritoneum | 1 | 2005 | 9 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2015 | 2157 | 0.060 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2005 | 16 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 37 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 21 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 33 | 0.060 |
Why?
|
| Solubility | 1 | 2005 | 139 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2017 | 48 | 0.060 |
Why?
|
| Microsatellite Instability | 1 | 2025 | 48 | 0.060 |
Why?
|
| Earthquakes | 1 | 2024 | 7 | 0.060 |
Why?
|
| Mitochondria | 1 | 2008 | 523 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 183 | 0.050 |
Why?
|
| Proteomics | 1 | 2026 | 378 | 0.050 |
Why?
|
| Syntenins | 1 | 2023 | 1 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2005 | 456 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2023 | 76 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 65 | 0.050 |
Why?
|
| Aging | 1 | 2008 | 783 | 0.050 |
Why?
|
| Prevalence | 1 | 2007 | 1612 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 267 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2008 | 1003 | 0.050 |
Why?
|
| Registries | 1 | 2024 | 437 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 314 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 532 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 1081 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 1180 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1542 | 0.040 |
Why?
|
| CA-125 Antigen | 1 | 2018 | 11 | 0.040 |
Why?
|
| Urocortins | 1 | 2017 | 4 | 0.030 |
Why?
|
| Galectins | 1 | 2018 | 30 | 0.030 |
Why?
|
| Receptors, Growth Factor | 1 | 2017 | 11 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 322 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 35 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 861 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 1067 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 6644 | 0.030 |
Why?
|
| Enkephalin, Methionine | 1 | 2016 | 6 | 0.030 |
Why?
|
| Enkephalin, Leucine | 1 | 2016 | 4 | 0.030 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2006 | 20 | 0.030 |
Why?
|
| beta-Endorphin | 1 | 2016 | 17 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 2676 | 0.030 |
Why?
|
| Apoptosis | 1 | 2023 | 1568 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 386 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 986 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1604 | 0.030 |
Why?
|
| Southeastern United States | 1 | 2013 | 64 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2013 | 51 | 0.030 |
Why?
|
| Community Networks | 1 | 2013 | 107 | 0.020 |
Why?
|
| Child | 1 | 2021 | 3443 | 0.020 |
Why?
|
| Ascitic Fluid | 1 | 2012 | 7 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2013 | 178 | 0.020 |
Why?
|
| Swimming | 1 | 2012 | 41 | 0.020 |
Why?
|
| Mast Cells | 1 | 2012 | 82 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 158 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 800 | 0.020 |
Why?
|
| Hippocampus | 1 | 2012 | 594 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 283 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 1772 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2005 | 4 | 0.010 |
Why?
|
| Intestine, Small | 1 | 2005 | 25 | 0.010 |
Why?
|
| Acute Disease | 1 | 2005 | 155 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 652 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1271 | 0.010 |
Why?
|